Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-021398

Director bought 12,600 shares at an average $7.76 ($97,830)

From the SEC's structured data for this filing

Trades in this filing

Nussbaum Ran · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-21 Purchase : show line 1 in the form +1,585 $7.55 $11,967 383,103 I
2018-03-21 Purchase : show line 2 in the form +3,255 $7.55 $24,575 786,919 I
2018-03-21 Purchase : show line 3 in the form +1,760 $7.55 $13,288 425,463 I
2018-03-22 Purchase : show line 4 in the form +1,441 $8.00 $11,528 384,544 I
2018-03-22 Purchase : show line 5 in the form +2,959 $8.00 $23,672 789,878 I
2018-03-22 Purchase : show line 6 in the form +1,600 $8.00 $12,800 427,063 I
Open-market purchases · 12,600 sh · avg $7.76 · $97,830
Loading xslF345X03/doc4.xml…